{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:05:04Z","timestamp":1788015904292,"version":"build-2784847793"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,20]]},"DOI":"10.7759\/cureus.65016","type":"journal-article","created":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T06:06:31Z","timestamp":1721541991000},"source":"Crossref","is-referenced-by-count":1,"title":["Unveiling the Connections Between Melanoma Differentiation-Associated Gene 5 (MDA5)-Positive Dermatomyositis and Its Potential Association With COVID-19: A Report of Two Cases"],"prefix":"10.7759","author":[{"given":"Temitope B","family":"Abegunde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Persad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sojibuchi","family":"Ojule","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Colgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu289","article-title":"Incidence and prevalence of inflammatory myopathies: a systematic review","volume":"54","author":"Meyer A","year":"2015","unstructured":"Meyer A, Meyer N, Schaeffer M, Gottenberg JE, Geny B, Sibilia J. Incidence and prevalence of inflammatory myopathies: a systematic review. Rheumatology (Oxford). 2015, 54:50-63. 10.1093\/rheumatology\/keu289","journal-title":"Rheumatology (Oxford)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.22978","article-title":"The role of myositis-specific autoantibodies in the dermatomyositis spectrum","volume":"14","author":"Ramesh HM Gude SS","year":"2022","unstructured":"Ramesh HM Gude SS, Venugopal S, Peddi NC, Gude SS, Vuppalapati S. The role of myositis-specific autoantibodies in the dermatomyositis spectrum. Cureus. 2022, 14:e22978. 10.7759\/cureus.22978","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246192","article-title":"Multidisciplinary approach to anti-MDA5 antibody-positive dermatomyositis associated with rapidly progressive interstitial lung disease","volume":"15","author":"Witkowska AB","year":"2022","unstructured":"Witkowska AB, Cowley S, Dempsey P, Stack J. Multidisciplinary approach to anti-MDA5 antibody-positive dermatomyositis associated with rapidly progressive interstitial lung disease. BMJ Case Rep. 2022, 15:246192. 10.1136\/bcr-2021-246192","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2017.1420521","article-title":"Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report","volume":"73","author":"De Backer E","year":"2018","unstructured":"De Backer E, Gremonprez F, Brusselle G, et al.. Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report. Acta Clin Belg. 2018, 73:413-7. 10.1080\/17843286.2017.1420521","journal-title":"Acta Clin Belg"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker518","article-title":"The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM","volume":"51","author":"Koga T","year":"2012","unstructured":"Koga T, Fujikawa K, Horai Y, et al.. The diagnostic utility of anti-melanoma differentiation-associated gene 5 antibody testing for predicting the prognosis of Japanese patients with DM. Rheumatology (Oxford). 2012, 51:1278-84. 10.1093\/rheumatology\/ker518","journal-title":"Rheumatology (Oxford)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.701","article-title":"Clinical characteristics of anti-MDA5 antibody-positive interstitial lung disease","volume":"9","author":"Kaenmuang P","year":"2021","unstructured":"Kaenmuang P, Navasakulpong A. Clinical characteristics of anti-MDA5 antibody-positive interstitial lung disease. Respirol Case Rep. 2021, 9:e00701. 10.1002\/rcr2.701","journal-title":"Respirol Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.791348","article-title":"Presence of anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: a retrospective cohort study","volume":"12","author":"Wang G","year":"2021","unstructured":"Wang G, Wang Q, Wang Y, et al.. Presence of anti-MDA5 antibody and its value for the clinical assessment in patients with COVID-19: a retrospective cohort study. Front Immunol. 2021, 12:791348. 10.3389\/fimmu.2021.791348","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/art.41105","article-title":"Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis","volume":"72","author":"Tsuji H","year":"2020","unstructured":"Tsuji H, Nakashima R, Hosono Y, et al.. Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis. Arthritis Rheumatol. 2020, 72:488-98. 10.1002\/art.41105","journal-title":"Arthritis Rheumatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead063","article-title":"High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis","volume":"62","author":"Chen X","year":"2023","unstructured":"Chen X, Shu X, He L, Yang H, Lu X, Wang G, Ge Y. High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis. Rheumatology (Oxford). 2023, 62:3302-9. 10.1093\/rheumatology\/kead063","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/ar3547","article-title":"Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan","volume":"2011","author":"Muro Y","unstructured":"Muro Y, Sugiura K, Hoshino K, Akiyama M, Tamakoshi K. Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan. Arthritis Res Ther. 2011:214. 10.1186\/ar3547","journal-title":"Arthritis Res Ther"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-022-05176-3","article-title":"New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review","volume":"42","author":"Holzer MT","year":"2022","unstructured":"Holzer MT, Krusche M, Ruffer N, Haberstock H, Stephan M, Huber TB, K\u00f6tter I. New-onset dermatomyositis following SARS-CoV-2 infection and vaccination: a case-based review. Rheumatol Int. 2022, 42:2267-76. 10.1007\/s00296-022-05176-3","journal-title":"Rheumatol Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.1064","article-title":"A case of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated rapidly progressive interstitial lung diseases developed after administration of COVID-19 vaccine and subsequent pneumococcal vaccine","volume":"10","author":"Takahashi S","year":"2022","unstructured":"Takahashi S, Kato A, Hashimoto K, Takehara T, Ishioka K, Takanashi S. A case of anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis-associated rapidly progressive interstitial lung diseases developed after administration of COVID-19 vaccine and subsequent pneumococcal vaccine. Respirol Case Rep. 2022, 10:e01064. 10.1002\/rcr2.1064","journal-title":"Respirol Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq149","article-title":"Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis","volume":"49","author":"Gono T","year":"2010","unstructured":"Gono T, Kawaguchi Y, Satoh T, et al.. Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis. Rheumatology (Oxford). 2010, 49:1713-9. 10.1093\/rheumatology\/keq149","journal-title":"Rheumatology (Oxford)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcv068","article-title":"Anti-MDA5 dermatomyositis and progressive interstitial pneumonia","volume":"109","author":"Silveira MG","year":"2016","unstructured":"Silveira MG, Selva-O'Callaghan A, Ramos-Terrades N, Arredondo-Agudelo KV, Labrador-Horrillo M, Bravo-Masgoret C. Anti-MDA5 dermatomyositis and progressive interstitial pneumonia. QJM. 2016, 109:49-50. 10.1093\/qjmed\/hcv068","journal-title":"QJM"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/255077-unveiling-the-connections-between-melanoma-differentiation-associated-gene-5-mda5-positive-dermatomyositis-and-its-potential-association-with-covid-19-a-report-of-two-cases","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T06:06:33Z","timestamp":1721541993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/255077-unveiling-the-connections-between-melanoma-differentiation-associated-gene-5-mda5-positive-dermatomyositis-and-its-potential-association-with-covid-19-a-report-of-two-cases"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.65016","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,20]]}}}